Michelle Floris-Moore, MD
Basic profileUniversity of North Carolina at Chapel Hill
Michelle Floris-Moore is an Infectious Disease physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 101 publications with 2,092 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Univ North Carolina Division Of Infectious Diseases
130 Mason Farm Road, Cb# 7030
Chapel Hill, NC 275997030
Telephone
919-966-4733Registry record last updated 27 Nov 2007.
Clinical trials
1 registered study on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20251 payment
- Gilead Sciences, Inc.Program year20251 payment
- ViiV Healthcare CompanyProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
72.3%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor28.1%Tivicay59%Dovato41%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor19.8%Descovy100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
16.2%Statin16.2%Atorvastatin Calcium100%Part D<11 patientsRespiratory
6.7%beta2-Adrenergic Agonist6.7%Albuterol Sulfate Hfa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- UNC MACS/WIHS Combined Cohort Study Clinical Research Site
Univ of North Carolina Chapel Hill
FY2025$2,752,661U01HL146194 - UNC MACS/WIHS Combined Cohort Study Clinical Research Site
Univ of North Carolina Chapel Hill
FY2024$2,702,913U01HL146194
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”